BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

504 related articles for article (PubMed ID: 3391251)

  • 1. Effects of cadmium on in vitro and in vivo erythropoiesis: erythroid progenitor cells (CFU-E), iron, and erythropoietin in cadmium-induced iron deficiency anemia.
    Sakata S; Iwami K; Enoki Y; Kohzuki H; Shimizu S; Matsuda M; Moriyama T
    Exp Hematol; 1988 Aug; 16(7):581-7. PubMed ID: 3391251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hematopoiesis in the rat: quantitation of hematopoietic progenitors and the response to iron deficiency anemia.
    Kimura H; Finch CA; Adamson JW
    J Cell Physiol; 1986 Feb; 126(2):298-306. PubMed ID: 3944211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blockade of the in vitro effects of testosterone and erythropoietin on Cfu-E and Bfu-E proliferation by pretreatment of the donor rats with cyproterone and flutamide.
    Malgor LA; Valsecia M; Vergés E; De Markowsky EE
    Acta Physiol Pharmacol Ther Latinoam; 1998; 48(2):99-105. PubMed ID: 9695882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythroid progenitor cells (CFU-E*) from Friend virus-infected mice undergo 55Fe suicide in vitro in the absence of added erythropoietin.
    Del Rizzo DF; Axelrad AA
    Exp Hematol; 1985 Nov; 13(10):1055-61. PubMed ID: 4054246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo suppression of erythropoiesis by tumor necrosis factor-alpha (TNF-alpha): reversal with exogenous erythropoietin (EPO).
    Johnson CS; Cook CA; Furmanski P
    Exp Hematol; 1990 Feb; 18(2):109-13. PubMed ID: 2303102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies of W mutant mice provide evidence for alternate mechanisms capable of activating hematopoietic stem cells.
    Miller CL; Rebel VI; Lemieux ME; Helgason CD; Lansdorp PM; Eaves CJ
    Exp Hematol; 1996 Feb; 24(2):185-94. PubMed ID: 8641340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term oral cadmium produces bone marrow hypoplasia in mice.
    Hays EF; Margaretten N
    Exp Hematol; 1985 Mar; 13(3):229-34. PubMed ID: 3979472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of normal human erythropoiesis by human recombinant DNA-produced alpha-2-interferon in vitro.
    Mamus SW; Oken MM; Zanjani ED
    Exp Hematol; 1986 Dec; 14(11):1015-22. PubMed ID: 3780887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2'5'-adenylate inhibition of erythropoietin-dependent colony formation.
    Orlic D; Quaini F; Konski AA; Wu JM
    Stem Cells (1981); 1982; 1(4-5):261-8. PubMed ID: 7147092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythroid progenitors in anemic Belgrade laboratory (b/b) rats.
    Pavlović-Kentera V; Basara N; Biljanović-Paunović L; Vasiljevska M; Rolović Z
    Exp Hematol; 1989 Aug; 17(7):812-5. PubMed ID: 2753090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukine-17-induced inhibitory effect on late stage murine erythroid bone marrow progenitors.
    Bugarski D; Krstić A; Vlaski M; Petakov M; Jovcić G; Stojanović N; Milenković P
    Eur Cytokine Netw; 2004; 15(3):247-54. PubMed ID: 15542450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of fibroblasts on the growth of erythroid progenitor cells in vitro.
    Ghio R; Bianchi G; Löwenberg B; Dicke KA; Ajmar F
    Exp Hematol; 1977 Sep; 5(5):341-7. PubMed ID: 902701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stem cell factor (c-kit ligand) enhances the interleukin-9-dependent proliferation of human CD34+ and CD34+CD33-DR- cells.
    Lemoli RM; Fortuna A; Fogli M; Motta MR; Rizzi S; Benini C; Tura S
    Exp Hematol; 1994 Aug; 22(9):919-23. PubMed ID: 7520394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal erythroid cell production during erythropoietin treatment of mice occurs by exploiting the splenic microenvironment.
    Nijhof W; Goris H; Dontje B; Dresz J; Loeffler M
    Exp Hematol; 1993 Apr; 21(4):496-501. PubMed ID: 8462658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo effects of recombinant human erythropoietin on bone marrow hematopoiesis in patients with chronic renal failure.
    Biljanović-Paunović L; Djukanović L; Lezaić V; Stojanović N; Marisavljević D; Pavlović-Kentera V
    Eur J Med Res; 1998 Dec; 3(12):564-70. PubMed ID: 9889177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of an aplastic anemia urinary extract on mouse erythroid progenitor cells in vivo.
    Kamamoto T; Kuriya S; Murphy MJ
    Exp Hematol; 1988 May; 16(4):268-73. PubMed ID: 3360064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulatory effect of human insulin on erythroid progenitors (CFU-E and BFU-E) in human CD34+ separated bone marrow cells and the relationship between insulin and erythropoietin.
    Aoki I; Taniyama M; Toyama K; Homori M; Ishikawa K
    Stem Cells; 1994 May; 12(3):329-38. PubMed ID: 7521243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hematopoietic stem cells in the hereditarily anemic Belgrade laboratory (b/b) rat.
    Ivanović Z; Milenković P; Vasiljevska M; Dekić M
    Exp Hematol; 1995 Oct; 23(11):1218-23. PubMed ID: 7556533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement of erythroid toxicity by lentinan and erythropoietin in mice treated with chemotherapeutic agents.
    Takatsuki F; Miyasaka Y; Kikuchi T; Suzuki M; Hamuro J
    Exp Hematol; 1996 Feb; 24(3):416-22. PubMed ID: 8599970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship of erythropoietin and iron metabolism to red blood cell production in humans.
    Adamson JW
    Semin Oncol; 1994 Apr; 21(2 Suppl 3):9-15. PubMed ID: 8202725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.